@mm.medicalaesthetics's HCG claims need context

What did @mm.medicalaesthetics actually say?

The creator argues that HCG is "very critical, very important" for any man on injectable testosterone. The core logic: exogenous testosterone suppresses luteinizing hormone (LH), which causes the testes to stop producing testosterone and, over time, shrink. HCG, she says, mimics LH, keeps the testes working, prevents atrophy, and makes coming off testosterone less brutal. She also claims men who have been on testosterone without HCG for years can reach a point where testicular drop is impossible and painful.

That is a lot of claims packed into a short video. Some are grounded in real physiology. Others are overstated. Let's separate them.

Does the science back this up?

The LH suppression mechanism is real and well-documented. The claim that HCG helps preserve testicular volume and intratesticular testosterone also has legitimate support. But calling it universally "critical" goes further than the evidence allows.

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, reducing LH and FSH. This is not controversial. Studies confirm that intratesticular testosterone drops sharply on TRT alone. Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed that intratesticular testosterone concentrations fell by roughly 94% in men on exogenous testosterone compared to controls, and that low-dose HCG (125 IU every other day) maintained intratesticular testosterone close to normal levels. That is real, meaningful data.

On testicular volume, the picture is less clean. Some degree of testicular atrophy on TRT is common, but not universal. And the severity varies considerably between individuals. The claim that years of TRT without HCG leads to irreversible, painful atrophy that prevents testicular descent is not supported by consistent published evidence. It may reflect clinical observation, but presenting it as a predictable outcome for all men is an overreach.

What did they get wrong (or right)?

Credit where it is due: the basic physiology here is accurate. LH suppression on TRT is real. HCG does act as an LH analog. Intratesticular testosterone does drop on TRT without HCG. These are not fringe claims.

However, there are real problems with this video.

• The creator says HCG "stimulates your luteinizing hormone." This is technically backwards. HCG does not stimulate LH. It mimics LH by binding to LH receptors on Leydig cells. The distinction matters clinically.
• Framing HCG as "critical" for every man on injectable testosterone ignores that many men on TRT do not use HCG, do not experience clinically significant atrophy, and do fine. Guidelines from the American Urological Association and the Endocrine Society do not mandate HCG co-administration with TRT.
• The claim about permanent painful testicular fixation in long-term TRT users is the weakest link. It may happen in rare cases, but presenting it as a known, predictable complication for men who skipped HCG is not backed by the published literature reviewed here.
• She correctly notes that HCG can ease the transition off testosterone by preserving endogenous production. Liu et al. (2002, Journal of Clinical Endocrinology and Metabolism) support that HCG stimulates testosterone recovery in hypogonadal men, which is relevant context for men considering coming off TRT.

What should you actually know?

HCG is a legitimate, commonly used adjunct to TRT. It is not snake oil. For men who care about fertility preservation, testicular volume, or keeping the door open to coming off testosterone, it is worth a serious conversation with a prescribing clinician.

But the word "critical" is doing too much work here. HCG use on TRT is a clinical choice, not a universal requirement. Ramasamy et al. (2015, Fertility and Sterility) found that HCG maintained sperm production and intratesticular testosterone in men on TRT, supporting its use in fertility-conscious patients specifically. That is not the same as saying every man on a testosterone injection needs it.

HCG availability also changed significantly in the US after the FDA reclassified it in 2020, restricting compounded HCG and pushing the market toward kisspeptin, gonadorelin, and enclomiphene as alternatives. A video recommending HCG without acknowledging that regulatory context leaves viewers with incomplete information.

If you are on TRT and wondering whether HCG is right for you, that is a legitimate question. The answer depends on your goals, your baseline testicular function, and whether fertility matters to you right now. It is not a one-size-fits-all add-on.